9 January 2025 in Journal of Bone and Joint Surgery
Background: The financial and resource burden of management of olecranon fractures in the elderly is likely to increase with an aging population. There is limited evidence guiding treatment choice in this cohort. This study aimed to determine whether operative treatment of displaced olecranon fractures in elderly patients provides superior 12-month functional outcomes compared to nonoperative treatment. Methods: A multicenter pragmatic randomized controlled trial was conducted across 24 hospitals in Australia and New Zealand. Patients aged ≥75 years presenting with an acute (within 14 days), displaced, closed, isolated olecranon fracture were included. Operative treatment involved reduction and stabilization using tension band wiring or plate fixation. Nonoperative treatment consisted of a sling for comfort and early movement as tolerated. The primary outcome was the Disabilities of the Arm, Shoulder and Hand (DASH) score at 12 months. Secondary outcomes were the DASH score at 3 months and pain, quality of life, Mayo Elbow Performance Score (MEPS), active elbow range of motion, and complication rate at 3 and 12 months. Data were analyzed based on an intention-to-treat principle, with sensitivity analyses using as-treated groups. Results: Sixty participants were randomized, 27 to the operative group (mean age and standard deviation [SD], 83 ± 5.8 years; 22 [81%] females) and 33 to the nonoperative group (mean age, 82 ± 4.5 years; 23 [70%] females), with no significant difference in baseline characteristics. There was no significant difference (mean difference, −6.6; 95% confidence interval [CI] = −14.9 to 1.8; p = 0.12) in the mean DASH scores at 12 months (the primary outcome) between the operative (12.3 ± 14) and nonoperative (18.9 ± 18) groups. Although active elbow extension was significantly superior in the operative group at 12 months, no other secondary outcome differed significantly between groups at 12 months. Conclusions: The study found no significant difference in DASH scores at 12 months between the operative and nonoperative groups. This supports nonoperative treatment as a reasonable option for displaced stable olecranon fractures in elderly patients. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
20 July 2024 in JSES International
Coronoid fracture size is one important factor in decision-making on surgical vs. nonsurgical management. There is currently no reliable, standardized technique to measure coronoid fracture size or bone loss. Hence, decision-making remains arbitrary, and recommendations made in the literature are unreliable. The aim of the study was to develop and assess a simple, reliable computed tomography (CT)-based technique that allows measurement of apical and anteromedial facet (AMF) coronoid height and bone loss. To achieve this, we sought to understand normal coronoid height across a large patient cohort, and whether the new technique was sensitive at detecting bone loss in patients with a fracture. 163 CT scans were manually formatted in the plane of the proximal ulna. A best fit circle was drawn in the greater sigmoid notch on the sagittal section. The coronoid coverage height (CCH) was defined as the distance (in mm) measured at 90° from the greater sigmoid notch floor to a line between the olecranon and coronoid tips (or fracture base in fractured coronoids), bisecting the center of the circle. The coronoid height index (CHI) was calculated as a % by dividing the CCH by the diameter of the circle. The measurements were performed at the coronoid apex and the center of the AMF in 108 intact coronoids to understand normative values and 55 fractured coronoids to assess the sensitivity of the technique at detecting bone loss. Measurements were independently performed by two investigators, and interobserver reliability was assessed with weighted Cohen’s kappa (ĸ) and intraclass correlation coefficient. For intact coronoids, the mean CCH was 11.4 ± 1.4 mm at the apex and 11.6 ± 1.3 mm at the AMF. The mean CHI was 56.7 ± 4.9% at the apex and 41.1 ± 3.6% at the AMF. For fractured coronoids, the mean CCH and CHI were significantly lower (P < .001) at both the apical (9.7 ± 1.4 mm, 45.8% ± 6.5%) and AMF (9.8 ± 1.6 mm, 33.9% ± 6.5%) positions, confirming that the technique was capable of detecting coronoid bone loss. While the CCH (a metric measurement) was significantly higher in men than in women (P < .001), the CHI (a proportion) demonstrated no significant difference at both the apex (P = .06) and AMF (P = .91). Interobserver reliability was good to excellent across all parameters. CHI is a reliable CT-based technique to assess coronoid height and bone loss that is independent of patient size and can be used for clinical and research purposes.